B+
Bull case
25%
Probability
Target price
$130.00
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
BNTX
BioNTech SECNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The bull case is a cash-backed oncology transition: BioNTech's verified Q1 filing cited €16.8 billion of cash, cash equivalents, and securities, six late-stage 2026 data readouts, and five additional pivotal pumitamig trials with Bristol Myers Squibb. Positive data and partner validation could support multiple expansion.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +6.0.
What can break
Declining or seasonal COVID vaccine demand may keep revenue visibility weak.
Momentum
60
Value
50
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $95.00 · Bull $130.00 · Bear $70.00Analysis 2026-08-05; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-14 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-05 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-14
Investment thesis
As of 2026-09-14
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-14. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $118.34
Why
Momentum60 · Δ7d -6.4
Value50 · Δ7d -0.0
Sentiment61 · Δ7d +6.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +6.0.
Contradictions & invalidation
- • Declining or seasonal COVID vaccine demand may keep revenue visibility weak.
- • Founder and leadership transition plans could add execution uncertainty during the oncology shift. [#SEC-6K-2026-05-05]
- • COVID revenue remains seasonal and pressured while R&D investment and losses persist.
Catalyst clock
2026-08-05
Post-print skepticism and COVID revenue erosion
Lead driver: Sentiment · See AI snapshot
Momentum
60
9% active weight
Current posture
7d trendFlat
Δ7d
-6.4
Δ21d
+2.5
Value
50
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.0
Sentiment
61
62% active weight
Current posture
7d trendImproving
Δ7d
+6.0
Δ21d
+21.7
Why this grade
Composite grade C. Momentum 59.8 / Value 49.8 / Sentiment 61.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-05. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$95.00
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$70.00
Analysis reference price unavailable
Analysis 2026-08-05 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$23.01B
Beta
1.49
Shares Out
251.2M
P/E (TTM) · Derived
-17.3
P/S (TTM)
6.30
P/FCF (TTM) · Derived
43.71
Rev YoY
-58.5%
EPS YoY
+108.4%
Gross Margin
+63.9%
Op Margin
-37.6%
Net Debt
-$17.12B
Current Ratio
7.85
As of 2026-09-14 • Updated nightlySource: Internal modelMethods & Data